Medartis said the acquisition of the Warsaw, Ind.-based company will allow it to expand its lower and upper extremities business in the U.S. The company’s leadership team, including CEO Rod Mayer, will stay in place, according to Medartis CEO Christoph Brönnimann.
Medartis said it will purchase Nextremities for up to $70 million, with an initial payment of $40 million upon closing of the deal, which is expected to be completed during the first half of this year.
Medartis said the first products under its ownership are expected to be launched in 2023.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
